1.CD Bioparticles
Provide one-stop customization service of gene therapy for academic and industrial customers.
2.Nucleic acid services platform
Gene therapy is developing into precise medicines that can manipulate specific genes in the treatment of serious diseases and vaccines development. To effectively function in vivo, reliable delivery systems are very important to the nucleic acids for protecting them from degradation and allowing effective cellular uptake and release. Based on profound scientific research accumulation, strong R&D strength and continuous technical support, CD Bioparticles could provide customers with one-stop customization service as:
Nucleic acid services
Design
Synthesis
Modifications
Delivery systems development
Polymer-based nanoparticles
Liposomes
Cell-based nanoparticles
Viral Vectors
Characterization
Physical characterization
Cell characterization
Animal studies
Design
According to the name of the disease or the gene, search the database and literature for the
sequence of the nucleic acid, and select the proper CDS for synthesis.
Synthesis
In Vitro Transcription (IVT)
Chemical synthesis for siRNA, mRNA, DNA, plasmid, ASO, sgRNA, shRNA
The corresponding QC testing services
Modifications
* Other modifications if needed.
5`-Terminal
Cap0/ Cap1/Cap2, Fluorescent Cap, IRES/MS2,
UTR modification…
3`-Terminal
Poly(A) synthesis, UTR modification…
Code Region:
m1ψ, m5C, 2'-OMe,
Pseudo-Uridine, LNA, N6 methyladenine, 5 methylcytidune…
3.Delivery system development platforms
Polymer-based nanoparticles
Due to the wide range of sources and low immunogenicity, cationic polymers, such as PEI, dendrimers,
chitosan, gelatin are widely used nanoscales delivery systems for gene therapy.
Liposomes
With the similar structure of cell membrane, liposomes are considered to be a safer and more effective delivery system. Its flexibility and robustness in lipid structure, composition, ratio and preparation methods make liposomes an important artificial carrier for gene therapy. Targeting ligands, such as peptides, antibodies have been successfully applied in liposomes to achieve
active targeting delivery to specified area. Furthermore, encapsulating fluorescent dyes in liposomes is very beneficial for later tracking and imaging studies.
Lipid nanoparticles (LNPs)
High nucleic acid loading
Stable in vivo
Low toxicity
Commercial LNPs
SM-102/MC3/ALC-0315 for research only
FDA approved
Ideal delivery model
Fluorescent liposomes
Biological tracer
Visual distinction
LNPs with target groups
Active targeting delivery
Tissue/cell selectivity
High bioavailability
www.cd-bioparticles.net
4.Delivery system development platforms
Cell-based nanoparticles
Exosomes are nanovesicles derived from cell membrane with natural targeting ability. CD Bioparticles provides various exosome production custom services for gene therapy research.
Viral vectors
Viral vectors are a tool commonly used in molecular biology to bring genetic material into cells. The principle is to use the molecular mechanism of viruses to transmit their genomes into other cells for infection. Its high effectiveness and tropism make viral vectors one of the most commonly used carriers for gene therapy. CD Bioparticles could provide a wild range of viral vectors for basic research and preclinical study.
Adenoviral vectors (Ads)
Non-integrating
Large packaging capacity
Broad tropism
Transduce (non-)dividing cells
High level expression
www.cd-bioparticles.net
Lentiviral vectors (LVs)
Integrating
Stable expression
Long-term expression
Retroviral vectors (RVs)
Integrating
Transduce dividing cells
Adeno-associated viral vectors (AAVs)
Non-integrating
Tissue tropisms
Various mutants
Low immunogenicity
High level and long-term